Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. | NPJ Precis Oncol | 2022 | 36115869 | PubTator, text mining | PubMed |
| HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. | J Exp Clin Cancer Res | 2022 | 36109787 | PubTator, text mining | PubMed |
| Hedgehog signaling activates a mammalian heterochronic gene regulatory network controlling differentiation timing across lineages. | Dev Cell | 2022 | 36108627 | PubTator, text mining | PubMed |
| Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates. | Environ Health Perspect | 2022 | 36102641 | PubTator, text mining | PubMed |
| ETV4 immunohistostaining is a sensitive and specific diagnostic biomarker for CIC-rearranged sarcoma of the central nervous system. | Histopathology | 2022 | 36102612 | PubTator, text mining | PubMed |
| Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis. | Biology (Basel) | 2022 | 36101460 | PubTator, text mining | PubMed |
| Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. | Front Mol Biosci | 2022 | 36072431 | PubTator, text mining | PubMed |
| Relationship between metabolic reprogramming and drug resistance in breast cancer. | Front Oncol | 2022 | 36059650 | PubTator, text mining | PubMed |
| Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis. | Front Immunol | 2022 | 36059531 | PubTator, text mining | PubMed |
| CIC missense variants contribute to susceptibility for spina bifida. | Hum Mutat | 2022 | 36054333 | PubTator, text mining | PubMed |
| Transcriptional profiles define drug refractory disease in myeloma. | EJHaem | 2022 | 36051067 | PubTator, text mining | PubMed |
| Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. | Genome Med | 2022 | 36045381 | PubTator, text mining | PubMed |
| Stable iPSC-derived NKX2-1+ lung bud tip progenitor organoids give rise to airway and alveolar cell types. | Development | 2022 | 36039869 | PubTator, text mining | PubMed |
| Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a pregnant woman: A case report and literature review. | Front Genet | 2022 | 36035131 | PubTator, text mining | PubMed |
| Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing. | Front Oncol | 2022 | 36033527 | PubTator, text mining | PubMed |
| Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts. | Int J Mol Sci | 2022 | 36012171 | PubTator, text mining | PubMed |
| Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature. | Cell Death Dis | 2022 | 36008383 | PubTator, text mining | PubMed |
| Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells. | Mar Drugs | 2022 | 36005485 | PubTator, text mining | PubMed |
| Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration. | Front Cell Dev Biol | 2022 | 35990603 | PubTator, text mining | PubMed |
| Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation. | J Hematol Oncol | 2022 | 35978321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=25